What You Should Know:
– Certara, a global leader in model-informed drug development, today announced an expanded collaboration with Merck, known as MSD outside of the United States and Canada.
– The strategic agreement will see…
Continue Reading
Allied health professionals (AHPs) should not wait for AI to come to them, write physiotherapists Christopher Efford and Charlie Winward
AI is everywhere. If you’re not using it, you’re probably considering it. It’s the…
Tim Barrow-Williams, Head of Drug Delivery at PA Consulting
Bill Hartman, Pharma and Medtech Design Expert at PA Consulting
Last year, the American Cancer Society predicted that in 2024, the US would reach two million annual…
Continue Reading
What You Should Know:
–DCAI today announced that Novo Nordisk has become a customer of the Gefion AI supercomputer.
– Through this agreement, Novo Nordisk will gain access to Gefion’s unparalleled computational capabilities to process vast datasets, with a…
Continue Reading
LIBD logo (PRNewsFoto/Lieber Institute for Brain Devel)
What You Should Know:
– The Lieber Institute for Brain Development (LIBD) is expanding its technology capabilities on Amazon Web Services (AWS), migrating its IT infrastructure to fully utilize…
Continue Reading
What You Should Know:
– Nicoya Lifesciences, Inc., a leading provider of advanced biologics characterization tools for drug discovery and development, today announced its acquisition of Applied Photophysics, a UK-based provider of biophysical characterization instrumentation.
– Applied Photophysics, bringing…
Continue Reading
What You Should Know:
– John Snow Labs, the AI for healthcare company announced its acquisition of WiseCube, a pioneer in biomedical knowledge graphs and AI-powered literature analysis. Financial details of the acquisition were not…
Continue Reading
Raj Indupuri, CEO and Co-Founder of eClinical Solutions
For years, the life sciences industry has been trying to address the same R&D challenges: rising costs, patient recruitment and retention, and difficulty maximizing ROI. Drug development is expensive,…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guests today are Dr. Nisim Peretz, Co-Founder and CEO, and Dr. Nir Waiskopf, CTO, at…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest is Matti Gill — CEO at AION Labs. Today, we’re diving into the cutting…
Continue Reading
